Impairment and recovery of CD8 T cell responses after sepsis
Impairment and recovery of CD8 T cell responses after sepsis
批准号:
9128672
负责人:
VLADIMIR P BADOVINAC
金额:
$30.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2019-07-31
关键词:
AddressAntigensApoptosisBacterial InfectionsCD8B1 geneCause of DeathCell physiologyCellsCellular ImmunityCharacteristicsCommunicable DiseasesComplexDataDendritic CellsDiseaseGoalsHealthHomeostasisIL2 geneImmuneImmune systemImmunityImmunosuppressionImpairmentIndividualInfectionIntensive Care UnitsIntrinsic factorKnowledgeLeadMaintenanceMemoryModelingOutcomePaperPatientsPopulationPredispositionPublicationsRecoveryResolutionRoleSepsisSeriesShapesSurvivorsSystemic infectionT cell differentiationT cell responseT-LymphocyteTherapeutic InterventionTimeVaccinationVaccinesVirus Diseasesadaptive immunitybasecancer immunotherapyimmune functionnovel strategiespathogenseptic
中文摘要
英文摘要
DESCRIPTION (provided by applicant): The ability to develop and sustain memory CD8 T cells post-infection or vaccination is a hallmark of the adaptive immune response and the basis for protective vaccination against infectious disease or in cancer immunotherapy. Since the degree of protection to infection depends on the functional characteristics (quality) and number (quantity) of memory CD8 T cells present at the time of antigen (Ag) re-exposure, understanding the mechanisms that govern naïve-to-memory CD8 T cell differentiation and long-term maintenance of the memory CD8 T cell pool are critical for achieving maximal protection. The outcome of viral or bacterial infections is determined by a series of complex interactions between the pathogen and infected host. Among these interactions the immune status of the host at the time of infection can have a major impact in the host susceptibility to disease. Polymicrobial sepsis represents a leading cause of death in most intensive care units, and patients who survive sepsis often display severely compromised immune function with deficits in innate and adaptive immune responses. One hallmark of the general immune suppression observed during polymicrobial sepsis is diminished T cell immunity. Consequently, septic patients and sepsis survivors are highly susceptible to new or previously encountered infections that are readily controlled by T cells when a normal, functioning immune system is present. In this regard, our recent papers revealed that sepsis significantly compromises the host's ability to
mount optimal CD8 T cell responses to newly introduced Ag presented in the context of systemic and localized model infections. Our data in these publications also revealed a previously unappreciated role for sepsis in shaping the quantity and functionality of infection- or
vaccine-induced pre-existing memory CD8 T cells. However, the extent of sepsis-induced changes the naïve and memory CD8 T cell pool and mechanisms that control their recovery, long-term maintenance and differentiation as well as potential therapeutic interventions to restore number and/or function of naïve and memory CD8 T cells in sepsis survivors are currently unknown. Thus, our long-term goal is to fully understand the functional consequences imposed on naïve and pre-existing memory CD8 T cell populations following sepsis induction. Our central hypothesis is that sepsis-induced apoptosis of Ag-specific naïve and/or memory CD8 T cells leads to long-lasting deleterious changes in the composition and/or function of CD8 T cell responses that ultimately result in diminished CD8 T cell responses to newly or previously encountered Ag delivered in the context of localized and systemic infections. We will address our long-term goal with the following specific aims: Aim 1 - Define the regulatory role of dendriti cells in sepsis-induced impairment of CD8 T cell immunity to newly introduced antigens. Aim 2 - Determine the extent to which CD8 T cell intrinsic factors control primary CD8 T cell responses after sepsis. Aim 3 - Determine the impact of sepsis on maintenance and function of pre-existing memory CD8 T cell responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses state
-
批准号:10557190
-
项目类别:
-
资助金额:$38.52万
-
财政年份:2020
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Evaluation of CC mice as an improved model for influenza immunity
-
批准号:10117187
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2020
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Differentiation of pathogen-specific memory CD8 T cell responses
-
批准号:9814211
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2019
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Molecular mechanisms controlling differentiation of memory CD8 T cells
-
批准号:8949463
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Impairment and recovery of CD8 T cell responses after sepsis
-
批准号:9302800
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:9884079
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10534144
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10317045
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10077814
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:8960855
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Cellular intermediates in stable memory CD8 T cell maintenance
-
批准号:8250161
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2012
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Cellular intermediates in stable memory CD8 T cell maintenance
-
批准号:8416310
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2012
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:7695307
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:8094471
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:7877845
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:8286365
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: